Virpax Pharmaceuticals Inc Forecast, price target & analysts
$0.00
0.00%
Nasdaq, Sep 14, 04:00 pm EDT.
Index
Industry
Virpax Pharmaceuticals Inc Target price 2026 - Analyst rating & recommendation
Powered by
Virpax Pharmaceuticals Inc Classifications & Recommendation
Hold
50%
Sell
50%
Virpax Pharmaceuticals Inc Price Target
| Target Price | $3.06 |
| Price | $0.00 |
| Potential |
3,059,900.00%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Virpax Pharmaceuticals Inc 2027 .
The average Virpax Pharmaceuticals Inc target price is $3.06.
This is
3,059,900.00%
register free of charge
$3.15
3,149,900.00%
register free of charge
$3.03
3,029,900.00%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend Virpax Pharmaceuticals Inc to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Virpax Pharmaceuticals Inc stock has an average upside potential 2027 of
3,059,900.00%
register free of charge
|
Current Virpax Pharmaceuticals Inc Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Maxim Group |
Locked
➜
Locked
|
Locked | Oct 09 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Maxim Group:
Locked
➜
Locked
|
Oct 09 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
